| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.022 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |